Drug Discovery · Charlottesville, VA · Founded 2019 · Privately Held (backing)
Developer of controlled metabolic accelerators designed to improve cardio-metabolic health. Rivus Pharmaceuticals is based in Charlottesville, VA and was founded in 2019. It was valued at $489 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $224 million across 4 recorded rounds; the latest was a $57 million later-stage round in Jan 2025.
PMV mark · valuation
$489.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$224.0M
Last round
Later Stage VC
Jan 2025
Cap table — not yet on record
Rivus Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rivus Pharmaceuticals with a free account
·Watch Rivus Pharmaceuticals: the Monday email on marks, rounds and moves
Where does Rivus Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Rivus Pharmaceuticals's 4 recorded funding rounds.
